J 2017

Importance of Preoperative Knowledge of the Biomarker HE4 in Early-stage Endometrial Cancer Regarding Surgical Management

PRESL, J., Petra OVESNÁ, Z. NOVOTNY, P. VLASAK, J. BOUDA et. al.

Základní údaje

Originální název

Importance of Preoperative Knowledge of the Biomarker HE4 in Early-stage Endometrial Cancer Regarding Surgical Management

Autoři

PRESL, J. (203 Česká republika), Petra OVESNÁ (203 Česká republika, garant, domácí), Z. NOVOTNY (203 Česká republika), P. VLASAK (203 Česká republika), J. BOUDA (203 Česká republika), J. KOSTUN (203 Česká republika), O. TOPOLCAN (203 Česká republika), R. KUCERA (203 Česká republika), Markéta BEDNAŘÍKOVÁ (203 Česká republika, domácí) a Vít WEINBERGER (203 Česká republika, domácí)

Vydání

Anticancer Research, Athens, The International Institute of Anticancer Research, 2017, 0250-7005

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30204 Oncology

Stát vydavatele

Řecko

Utajení

není předmětem státního či obchodního tajemství

Impakt faktor

Impact factor: 1.865

Kód RIV

RIV/00216224:14110/17:00098150

Organizační jednotka

Lékařská fakulta

UT WoS

000402173300069

Klíčová slova anglicky

CA125; HE4; endometrial cancer; preoperative staging

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 20. 3. 2018 17:44, Soňa Böhmová

Anotace

V originále

Aim: To analyze the utility of HE4 assessment in preoperative management of patients with early-stage endometrial cancer for stratification into low-risk and high-risk groups. Patients and Methods: The following data were prospectively collected from patients operated for endometrial cancer from 05/2012 till 9/2016; age, HE4, CA125, expert ultrasound examination of the pelvis, histotype, grade, FIGO stage. Results: In total, 124 patients were enrolled. A cut-off of >= 113 pmol/l HE4 demonstrated 40.3% sensitivity and 83.9% specificity for detection of high-risk patients. Correlations of HE4 with age (p<0.001), depth of myometrial invasion (p=0.001), clinical stage of the disease according to ultrasound - T1a vs. T1b (63.6 pmol/l vs. 110.6 pmol/l, p<0.001) were found. However, no correlation of HE4 with lymph node invasion (p=0.07) and tumor grade (p=0.212) was identified. Conclusion: HE4 levels correspond to clinical and FIGO stage of the disease. The sensitivity and specificity does not reach the transvaginal ultrasound results in preoperative assessment of the extent of the disease. Combination of HE4 with ultrasound does not improve the stratification of patients into low-risk and high-risk groups. Preoperative assessment of HE4 is useful providing no imaging method is available.